Insider sale
DYNE THERAPEUTICS, INC.
$15.45M
796.13K shares
What this filing means
FORDYNE B.V. plans to sell 796.13K shares of DYNE THERAPEUTICS, INC. valued at approximately $15.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/17/2026ACC: 0001969223-26-000712
796.13K
Shares to sell
$15.45M
Approx. market value
348.32K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
IPO Conversion of Shares
N/A
9/17/2020
348.32KTotal acquired348.32K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/17/2020 | IPO Conversion of Shares N/A | 348.32K | — |
| Total | 348.32K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
2.65K
Market value
$53.0K
4/22/2026
—Completed
Units to sell
8.30K
Market value
$166.1K
4/21/2026
—Completed
Units to sell
125.27K
Market value
$2.51M
4/20/2026
—Completed
Units to sell
211.97K
Market value
$4.30M
4/17/2026
—Completed
Units to sell
6.66K
Market value
$133.5K
4/16/2026
—Completed
Units to sell
92.96K
Market value
$1.89M
4/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
348.32K
Market value
$6.38M
6/17/2026
Total
Units
796.13K
Value
$15.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/22/2026 | 2.65K | $53.0K | — | Completed |
4/21/2026 | 8.30K | $166.1K | — | Completed |
4/20/2026 | 125.27K | $2.51M | — | Completed |
4/17/2026 | 211.97K | $4.30M | — | Completed |
4/16/2026 | 6.66K | $133.5K | — | Completed |
4/15/2026 | 92.96K | $1.89M | — | Completed |
| Planned — Approximate Date | ||||
6/17/2026 | 348.32K | $6.38M | Nasdaq | Planned |
| Total | 796.13K | $15.45M | ||